Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AGN-214868 in Postherpetic Neuralgia
2012-002240-24Phase 2Terminated
- Sponsor
- Allergan
- Start
- Aug 2012
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of senrebotase in postherpetic neuralgia (PHN), Neuralgia, sponsored by Allergan. Started Aug 2012; status: terminated.
02
Drugs
senrebotase
03
Conditions
postherpetic neuralgia (PHN)Neuralgia
Beyond the preview
Go deeper on 2012-002240-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002240-24.